Sexual and hormonal health
Erectile dysfunction
Erectile difficulty can involve blood vessels, nerves, medicines, anxiety or hormonal factors. It may be an early marker of cardiovascular disease.
Potential benefits explored
More reliable erections and sexual response.
PT-141 and kisspeptin are explored for central sexual signalling. Erection quality also depends on vascular and other causes that these research ideas may not address.
Practical interpretation
Assess vascular risk, medicines and psychological factors; established options such as PDE5 inhibitors often have a clearer role.
Meaningful outcomes: Erection reliability, satisfaction and relevant physical causes.
Compare the compounds studied for Erectile dysfunction
Members see the full evidence picture for this condition: every compound studied, graded per condition from strong human evidence through to preclinical-only and negative findings, with human and animal results, risks, combination evidence and cited sources — plus how each compound maps to the research materials we list, with live pricing and stock.
Research reference for laboratory materials only. Not medical advice and not a recommendation for human use. Research cut-off: 30 September 2026.